哪些COPD患者需要吸入性皮质类固醇?
1Paul M. Boylan is an assistant professor in the Department of Pharmacy: Clinical and Administrative Sciences at the University of Oklahoma Health Sciences Center's College of Pharmacy in Oklahoma City, Okla. The author has disclosed no potential conflicts of interest, financial or otherwise.
概括
吸入式支气管扩展剂是慢性阻塞性肺病 (COPD) 的标准. 吸入性皮质类固醇 (ICS) 可能有利于特定的COPD患者,包括那些患有eosinophilic表型或频繁恶化的患者.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 药理学 药理学是指药理学的学科.
背景情况:
- 吸入式支气管扩展剂是所有慢性阻塞性肺病 (COPD) 患者的基石治疗.
- 临床指南建议在特定的COPD患者小组中使用吸入式皮质类固醇 (ICS).
- 这些子组包括具有乙性COPD表型,频繁严重恶化或并发性喘的人.
研究的目的:
- 确定慢性阻塞性肺病 (COPD) 中最有可能从吸入性皮质类固醇 (ICS) 治疗中受益的患者个人资料.
- 为了明确在COPD管理中使用ICS的条件建议.
主要方法:
- 审查临床实践指南和相关文献.
- 分析证据支持在不同慢性阻塞性肺病 (COPD) 现型中使用吸入性皮质类固醇 (ICS).
- 确定与积极的ICS反应相关的患者特征.
主要成果:
- 吸入式支气管扩展剂是普遍推用于COPD的.
- 吸入性皮质类固醇 (ICS) 在患有eosinophilic表型的COPD患者中显示有条件的益处.
- 此外,ICS还建议COPD患者住院治疗或频繁严重恶化,以及喘患者使用.
结论:
- 在慢性阻塞性肺病 (COPD) 中使用吸入性皮质类固醇 (ICS) 的决定应根据特定的患者标准进行个性化.
- ICS对于患有eosinophilic炎症或有严重恶化的病史的COPD患者尤其有益.
- 同时存在的喘也可能表明ICS在COPD管理中的作用.
相关概念视频
01:26COPD: Management Using Bronchodilators and Corticosteroids
207
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
207
01:23Inhaled Medications
269
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
269
01:25Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
251
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
251
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
01:17Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442